AKT1 and breast cancer: This result indicated that TRIB3 decreases HER2 levels by reducing its stability and led us to postulate that the increased proliferation and enhanced AKT activation that was previously observed in TRIB3-silenced luminal B BC cell lines could be a result of HER2 signaling hyperactivation.